Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Merck Names Constantin Fest To Head Investor Relations Dept.

RELATED NEWS
Trade MRK now with 

Merck & Co. Inc. (MRK: Quote) announced that Constantin Fest will head its Investor Relations department as of January 1, 2013. He will succeed Joshua Young. Constantin Fest will report to Matthias Zachert, Chief Financial Officer of Merck.

Constantin Fest joined the Merck Investor Relations department in June 2012 and has a broad investor relations background. Prior to Merck, he worked for the Lanxess Investor Relations department and for its Treasury.

Click here to receive FREE breaking news email alerts for Merck & Co Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Twitter Inc. has replaced its head of product Daniel Graf just six months after luring him over from Google, according to multiple reports. Graf, previously known for his work leading Google Maps will retain his vice president of product title and work on Twitter's geolocation features, the Wall Street... LinkedIn Corp., the world's largest online professional network, said Thursday after the markets closed that its third quarter loss widened slightly from last year, as higher costs and expenses more than offset a 45% increase in revenue. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue. Visa Inc., the world's largest payment card processor, said Wednesday that its fourth quarter profit fell 10% from last year, hurt mainly by a hefty litigation provision even as revenue increased 9%. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.